Resistance to anti-infective drugs and the threat to public health

Cell

Volumn 124, Issue 4, 2006, Pages 671-675

  Heymann, David L ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; ANTIVIRUS AGENT; ARTEMISININ; CEPHALOSPORIN DERIVATIVE; CHLOROQUINE; DELAVIRDINE; EFAVIRENZ; FANSIDAR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; OSELTAMIVIR; PENICILLIN G; UNCLASSIFIED DRUG; ZENAMIVIR;

AGRICULTURE; ANIMAL HUSBANDRY; AQUACULTURE; DRUG COST; DRUG EFFECT; HEALTH CARE COST; HUMAN; INFECTION; MICROORGANISM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW;

ANIMALIA;

EID: 32944482036     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2006.02.009     Document Type: Note

References (16)

1. G.L. Armstrong, L.A. Conn, and R.W. Pinner JAMA 281 1999 61 66
2. CDC Centers for Disease Control and Prevention. High levels of adamantine resistance among influenza A (H3N2) viruses and interim guidelines for use of antivital agents, United States, 2005 -06 influenza season MMWR at http://www.cdc.gov/flu/han011406.htm 2005
3. S.E. Cosgrove Clin. Infect. Dis. 42 Suppl. 2 2006 S82 S89
4. V. Curtis, and S. Cairncross Lancet Infect. Dis. 5 2003 275 281
5. M.D. de Jong, T.T. Tran, H.K. Truong, M.H. Vo, G.J. Smith, V.C. Nguyen, V.C. Bach, T.Q. Phan, Q.H. Do, and Y. Guan N. Engl. J. Med. 353 2005 2667 2672
6. C. Dye, M.A. Espinal, C.J. Watt, M. Mbiaga, and B.G. Williams J. Infect. Dis. 185 2002 1197 1202
7. M. Escoto-Delgadillo, E. Vazquez-Valls, M. Ramirez-Rodriguez, A. Corona-Nakamura, G. Amaya-Tapia, N. Quintero-Perez, A. Panduro-Cerda, and B.M. Torres-Mendoza HIV Med. 6 2005 403 409
8. F. Fenner, D.A. Henderson, I. Arita, Z. Jezek, and I.D. Ladnyi Smallpox and Its Eradication 1988 World Health Organization Geneva
9. D.L. Heymann, and R.B. Aylward N. Engl. J. Med. 351 2004 1275 1277
10. M. Jung, K. Lee, H. Kim, and M. Park Curr. Med. Chem. 11 2004 1265 1284
11. W. Kondro Lancet 349 1997 1156
12. S.B. Levy The Antibiotic Paradox: How Miracle Drugs Are Destroying the Miracle 1992 Plenum Press New York
13. NAS US Environmental Protection Agency in Antimicrobial Resistance. Issues and Options, Forum on Emerging Infections page 53 1998 National Academy Press Washington, DC
14. S. Suttajit, A.K. Wagner, R. Tantipidoke, D. Ross-Degnan, and C. Sitthi-amorn Southeast Asian J. Trop. Med. Public Health 36 2005 489 497
15. WHO Removing Obstacles to Healthy Development http://www.who.int/ infectious-disease-report/index-rpt99.html 1999
16. WHO Global strategy for containment of antimicrobial resistance. Geneva, World Health Organization (WHO/CDS/CSR/DRS/2001.2) Further information available at http://www.who.int/emc/amr.html 2001